A multi-center phase II study of Doxil/carboplatin in patients with advanced or recurrent endometrial carcinoma

Trial Profile

A multi-center phase II study of Doxil/carboplatin in patients with advanced or recurrent endometrial carcinoma

Discontinued
Phase of Trial: Phase II

Latest Information Update: 31 Oct 2013

At a glance

  • Drugs Carboplatin (Primary) ; Doxorubicin liposomal (Primary)
  • Indications Endometrial cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Sep 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 06 Jun 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
    • 11 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top